US$ 24.98
bpc-157 canada legal status Public advisory BPC-157 is being promoted across
Description
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: Mitochondrial agents, N-acetylcysteine, and placebo
Individual results vary and are impacted by diet and exercise

Note: This service is only available to the age of 18 and above

Regulatory Status and Quality Considerations BPC-157 currently lacks approval from the United States Food and Drug Administration (FDA) or other major regulatory authorities for any therapeutic indication
